Rapport: Rutinebrug af CYP-test ved antipsykotisk behandling

51. Fleeman N, Dundar Y, Dickson R, Jorgensen A, Pushpakom S, McLeod C, et al.Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia:systematic review and meta-analyses. Pharmacogenomics J 2011 Feb;11(1):1-14.52. Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, et al. Failure torespond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapidhydroxylation. Br J Clin Pharmacol 1999 09;48(3):388-394.53. Arranz MJ, Dawson E, Shaikh S, Sham P, Sharma T, Aitchison K, et al.Cytochrome P4502D6 genotype does not determine response to clozapine. Br J ClinPharmacol 1995 04;39(4):417-420.54. Kohlrausch FB, Gama CS, Lobato MI, Belmonte-de-Abreu P, Callegari-JacquesSM, Gesteira A, et al. Naturalistic pharmacogenetic study of treatment resistance totypical neuroleptics in European-Brazilian schizophrenics. Pharmacogenet Genomics2008 07;18(7):599-609.55. Riedel M, Schwarz MJ, Strassnig M, Spellmann I, Muller-Arends A, Weber K, etal. Risperidone plasma levels, clinical response and side-effects. Eur Arch PsychiatryClin Neurosci 2005 08;255(4):261-268.56. Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, et al.Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelicvariations to the phenotype of drug response. Mol Psychiatry 2004 05;9(5):442-473.57. Mauri MC, Volonteri LS, Colasanti A, Fiorentini A, De Gaspari IF, Bareggi SR.Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationshipbetween plasma concentrations and clinical response. Clin Pharmacokinet2007;46(5):359-388.58. Prior TI, Baker GB. Interactions between the cytochrome P450 system and thesecond-generation antipsychotics. J Psychiatry Neurosci 2003 Mar;28(2):99-112.59. Molden E, Lunde H, Lunder N, Refsum H. Pharmacokinetic variability of aripiprazoleand the active metabolite dehydroaripiprazole in psychiatric patients. Ther DrugMonit 2006 Dec;28(6):744-749.60. Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance:Part I. Clin Pharmacokinet 2009;48(11):689-723.61. Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance:part II. Clin Pharmacokinet 2009;48(12):761-804.62. Steimer W, Zopf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, et al. Allelespecificchange of concentration and functional gene dose for the prediction of steadystateserum concentrations of amitriptyline and nortriptyline in CYP2C19 andCYP2D6 extensive and intermediate metabolizers. Clin Chem 2004 Sep;50(9):1623-1633.63. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic doseequivalents and dose-years: a standardized method for comparing exposure to differentdrugs. Biol Psychiatry 2010 Feb 1;67(3):255-262.92 Rutinebrug af CYP-test ved antipsykotisk behandling